Potassium Carbonate → HCID 178462824、化合物
反応式
[CH2:1]([N:3]1[C:7]([CH2:8]O)=[CH:6][N:5]=[CH:4]1)[CH3:2].C1C(=O)N([Cl:17])C(=O)C1.P(Br)(Br)Br.C(=O)([O-])[O-].[K+].[K+].[CH3:28][C:29]1[N:34]=[C:33]([SH:35])[N:32]=[C:31]([OH:36])[CH:30]=1>O1CCOCC1>[Cl:17][C:6]1[N:5]=[CH:4][N:3]([CH2:1][CH3:2])[C:7]=1[CH2:8][S:35][C:33]1[N:32]=[C:31]([OH:36])[CH:30]=[C:29]([CH3:28])[N:34]=1参加物
実験手順
To the solution of (1-ethyl-1H-imidazol-5-yl)methanol (1.26 g, 10 mmol) in dioxane (50 mL) in a 250 mL round bottom flask, was added NCS (1.38 g, 10 mmol). The resulting mixture was stirred at room temperature overnight. Dioxane was removed under vacuum, and the crude solid was dissolved in chloroform (40 mL), followed by addition of PBr3 (1.9 mL, 20 mmol). The resulting mixture was stirred at room temperature overnight. The solvent was then evaporated. The crude 5-(bromomethyl)-4-chloro-1-ethyl-1H-imidazole was dissolved in DMF (20 mL). Potassium carbonate (3 g) and 6-methyl-2-sulfanylpyrimidin-4-ol (1.4 g, 10 mmol) were added. The mixture was stirred at room temperature for 2 hours. DMF was removed under vacuum, and the residue was purified by column chromatography to provide 2-{[(4-chloro-1-ethyl-1H-imidazol-5-yl)methyl]sulfanyl}-6-methylpyrimidin-4-ol (100 mg, 3% overall yield); 1H NMR (400 MHz, CD3OD): δ 1.41 (t, 3H), 2.29 (s, 3H), 4.12 (q, 1H), 4.60 (s, 2H), 4.59 (m, 1H), 6.01 (br, 1H), 7.66 (s, 1H); M+ 285.
後処理
- customDioxane was removed under vacuum
- dissolutionthe crude solid was dissolved in chloroform (40 mL)
- stirringThe resulting mixture was stirred at room temperature overnight
- customThe solvent was then evaporated
- dissolutionThe crude 5-(bromomethyl)-4-chloro-1-ethyl-1H-imidazole was dissolved in DMF (20 mL)
- stirringThe mixture was stirred at room temperature for 2 hours
- customDMF was removed under vacuum
- customthe residue was purified by column chromatography
出典と根拠
- ORDレコード
- ord-88604c3d5fae430599fd4ea170dda59a
- 出典データセット
- uspto-grants-2015_05
- 特許番号
- US09040538B2
反応ノート
読み込み中…